A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer. (Q39580436)
scientific article published on 25 July 2012
Language:
(P31) (Q13442814)
(P50) (Q71283424)
(P304) 669-676
(P407) (Q1860)
(P433) 3
(P478) 31
(P577) Wednesday, July 25, 2012
(P921) (Q79460)
(Q3960572)
(Q420436)
(Q422248)
(Q181257)
(P1433) (Q2312231)
(P1476) "A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer" (language: en)
(P2093) Gary Hudes
Scott T Tagawa
Ming Qi
Xiang Qin
Thomas A Puchalski
Manjula Reddy
Mark Cornfeld
Mario Eisenberger
(P2860) (Q33943225)
(Q53277140)
(Q46365760)
(Q40801056)
(Q39898226)
(Q44503001)
(Q29616218)
(Q30657347)
(Q46412371)
(Q34308421)
(Q34023737)
(Q34023078)
(Q77464583)
(Q39487932)
(Q58681269)
other details
description scientific article published on 25 July 2012

External Links